Market Cap (In DKK)
20.19 Million
Revenue (In DKK)
2.35 Million
Net Income (In DKK)
-19.12 Million
Avg. Volume
897.6 Thousand
- Currency
- DKK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.06-0.22
- PE
- -
- EPS
- -
- Beta Value
- -0.344444
- ISIN
- DK0061670205
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Mr. Kim Baden-Kristensen
- Employee Count
- -
- Website
- https://www.brain-plus.com
- Ipo Date
- 2021-10-07
- Details
- Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was incorporated in 2012 and is based in Copenhagen, Denmark. Brain+ A/S was formerly a subsidiary of Brain+ Holding ApS.
More Stocks
-
AHGIFAlternate Health Corp.
AHGIF
-
REXR-PCRexford Industrial Realty, Inc.
REXR-PC
-
FIBRAPL14FIBRA Prologis
FIBRAPL14
-
TNIEFtonies SE
TNIEF
-
AIMIRT
-
UNIRUnieuro S.p.A.
UNIR
-
CCLDPCareCloud, Inc.
CCLDP
-
MDRM